<DOC>
	<DOCNO>NCT02957292</DOCNO>
	<brief_summary>The intrauterine device ( IUD ) long-term birth control method demonstrate high contraceptive efficacy effectiveness due high compliance , adherence persistence use . The IUD global prevalence rate around 14 % woman reproductive age . Side effect main reason IUD use discontinuation . The common reason copper IUD discontinuation increase menstrual bleeding , irregular bleeding dysmenorrhea , whereas case 52mg Levonorgestrel IUD irregular bleeding amenorrhea . In 2014 , new hormonal IUD containing13,5mg Levonorgestrel market Spain . There many study compare two Levonorgestrel IUDs . However , study compare IUD 13,5mg Levonorgestrel classic copper IUDs . The hypothesis trial Levonorgestrel ( 13,5mg ) IUD user menstrual bleeding pattern few day Copper 380 mm2 IUD user . This Phase IV , national single-center , randomize 1 : 1 , single-blind , comparative , parallel control trial .</brief_summary>
	<brief_title>A Study Compare Menstrual Bleeding Profile Among JaydessÂ® Copper Intrauterine Device ( IUD ) Users . COLIBRI STUDY ( Copper Levonorgestrel IUD Barcelona Research Initiative ) .</brief_title>
	<detailed_description />
	<mesh_term>Copper</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Healthy female subject . Parous nulliparous woman age 18 45 year ask IUD contraceptive method . History regular cyclic menstrual period range 21 35 day nonexcessive menstrual blood loss . Absolute contraindication IUD use , accord World Health Organization Medical Eligibility Criteria . Contraindications use 13,5 LNGIUD . Anemia . Use short longacting preparation contain sex hormone within 12 week IUD insertion . Known bleed irregularity . Pregnancy breastfeeding .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>